With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

ClearPoint Neuro on Monday announced FDA clearance of its Version 3.0 Navigation ... Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System Newly Launched Technology ...

PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx™, which is ...

Prism Johnson Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 5,974.84 Crore) operating in Cement sector. Prism Johnson Ltd. key Products/Revenue Segments include ...

After hours: February 18 at 5:29:36 p.m. EST ...

After hours: February 14 at 5:04:49 p.m. EST ...